Medical technologies provider Teleflex has obtained 510(k) approval from the US Food and Drug Administration (FDA) for its Arrow Triple lumen pressure injectable acute hemodialysis catheter.

Available for Arrow ErgoPack System, the catheter helps hospital to maintain conformity with current vascular access guidelines and standards, as well as provides maximal barrier protection against infections when inserting these lines.

Teleflex vascular division president Jay White said: "To support our goal of providing the right line for the right patient at the right time, adding the Arrow Triple Lumen Pressure Injectable Acute Hemodialysis Catheter to our hemodialysis portfolio provides options to clinicians when choosing the best catheter for their patient."

The company noted that it will partner with healthcare facilities to reduce vascular access related complications and its new catheter is another example of its commitment to this goal.

Teleflex provides solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care.

It markets products under the brands of Arrow, Deknatel, Hudson RCI, LMA, Pilling, Rusch and Weck.